<DOC>
	<DOC>NCT01331655</DOC>
	<brief_summary>The objective of this three-arm study is to evaluate the effect of a flexible extended regimen of an EE+DRSP containing OC on bleeding pattern and to investigate the compliance with daily pill intake when the investigational product is provided in a blister package or a compliance aiding dispenser with a pill reminder function. The third treatment arm will be a reference comparator arm of a standard 24+4 regimen of the identical hormone combination.</brief_summary>
	<brief_title>Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin America</brief_title>
	<detailed_description />
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Healthy female volunteers between 18 and 35 years of age (smokers up to 30 years, inclusive) who request contraceptive protection Pregnancy or lactation (less than 3 months since delivery, abortion, or lactation before start of treatment) Body mass index (BMI) &gt;/= 30.0 kg/m2 Presence or a history of venous or arterial thrombotic/thromboembolic events Repeated measurements of systolic blood pressure &gt; 140 mmHg and/or diastolic blood pressure &gt; 90 mmHg Presence or history of liver tumors (benign or malignant), severe hepatic disease, jaundice and/or pruritus related to cholestasis, cholestatic jaundice associated with pregnancy or previous combined oral contraceptive (COC) use Uncontrolled diabetes mellitus and/or diabetes mellitus with vascular involvement Severe dyslipoproteinemia Malignant or premalignant disease Uncontrolled thyroid disorder Chronic inflammatory bowel disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>